Novel Epigenetic Biomarker for Prematurity Related Neurodevelopmental Disorders in Childhood
Structural Variations of the Neural Genome as Prognostic Biomarkers for Prematurity Related Neurodevelopmental Disorders in Childhood
1 other identifier
interventional
104
1 country
1
Brief Summary
Preterms are early exposed to a stressful environment (i.e. excessive sensory stimulation and paucity of parental contact) with subsequent detrimental effects on brain maturation and neurodevelopmental outcomes. In contrast, early interventions seem to reduce stress exposure and promote neurodevelopment. The brain functional plasticity in response to environmental experiences can be partly attributed to changes in DNA methylation. In this context, LINE-1 (L1) promoter (18% of human genome) methylation/demethylation has been associated with L1 somatic mobilization in the brain genomes, contributing to experience-driven brain plasticity; this mechanism being deregulated in important neurological disease. This study aims at identifying and characterizing the role of L1 DNA repeats as a novel biomarker to predict long-term neurodevelopmental outcome in preterm infants. In addition, the study's secondary goal will be to define a preventive approach, based on early intervention strategies, for improving long-term neurodevelopmental outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2020
CompletedFirst Posted
Study publicly available on registry
November 5, 2020
CompletedStudy Start
First participant enrolled
December 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 21, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2025
CompletedMay 1, 2025
April 1, 2025
4.3 years
October 23, 2020
April 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
L1 Promoter Methylation Levels on Biological Materials
Epigenetic analysis is performed on biological materials: cord blood sample and buccal swab at birth, peripheral blood sample and buccal swab at NICU discharge/term equivalent age, buccal swab collected during the follow up assessment at 12 and 24 months of corrected age.
Up to 24 months corrected age
Secondary Outcomes (6)
Conventional and advanced brain Magnetic Resonance Imaging (MRI)
Term equivalent age, approximately 40 weeks postmenstrual age
Neurological Examination
Term equivalent age, approximately 40 weeks postmenstrual age
General Movements Examination
Term equivalent age, approximately 40 weeks postmenstrual age
Visual Assessment
Term equivalent age, approximately 40 weeks postmenstrual age
Neurodevelopmental Outcome
Up to 24 months corrected age
- +1 more secondary outcomes
Study Arms (1)
Early Intervention
EXPERIMENTALAll the enrolled preterm infants are assigned to receive the early neurodevelopmental intervention during the NICU stay.
Interventions
The early intervention (EI) is delivered during the NICU stay. It is a multisensory intervention which consists in three parts: parental training, massage therapy and visual interaction. The EI is first focused on parental training, according to PremieStart Protocol, in order to train parents to: recognize signs of infant stress and alert-available behavior through the identification of infant's behavioral states; adopt principles of graded stimulation; sustain infant's attention and respond to infant's cues; optimize interactions and avoid overwhelming infants through facilitation strategies. The program is held in eight main sessions and one additional post-discharge session. In addition, parents are trained and invited to daily promote preterm baby massage therapy and visual interaction (visual fixation/tracking and visual attention).
Eligibility Criteria
You may qualify if:
- Gestational age at birth between 24+0 and 32+6 weeks
- Mothers age over 18 years
- Good comprehension of the Italian language
- Written informed consent signed by both parents
You may not qualify if:
- Infants with major genetic disorders and malformations
- Parents declined study participation
- Single-parent family
- Parents with obvious cognitive or psychiatric disorders and drug addiction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NICU, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan, 20122, Italy
Related Publications (5)
Fontana C, De Carli A, Ricci D, Dessimone F, Passera S, Pesenti N, Bonzini M, Bassi L, Squarcina L, Cinnante C, Mosca F, Fumagalli M. Effects of Early Intervention on Visual Function in Preterm Infants: A Randomized Controlled Trial. Front Pediatr. 2020 Jun 4;8:291. doi: 10.3389/fped.2020.00291. eCollection 2020.
PMID: 32582595BACKGROUNDNewnham CA, Milgrom J, Skouteris H. Effectiveness of a modified Mother-Infant Transaction Program on outcomes for preterm infants from 3 to 24 months of age. Infant Behav Dev. 2009 Jan;32(1):17-26. doi: 10.1016/j.infbeh.2008.09.004. Epub 2008 Nov 20.
PMID: 19026450BACKGROUNDBedrosian TA, Quayle C, Novaresi N, Gage FH. Early life experience drives structural variation of neural genomes in mice. Science. 2018 Mar 23;359(6382):1395-1399. doi: 10.1126/science.aah3378.
PMID: 29567711BACKGROUNDRicci D, Romeo DM, Serrao F, Cesarini L, Gallini F, Cota F, Leone D, Zuppa AA, Romagnoli C, Cowan F, Mercuri E. Application of a neonatal assessment of visual function in a population of low risk full-term newborn. Early Hum Dev. 2008 Apr;84(4):277-80. doi: 10.1016/j.earlhumdev.2007.10.002. Epub 2007 Nov 8.
PMID: 17996405BACKGROUNDGuzzetta A, Baldini S, Bancale A, Baroncelli L, Ciucci F, Ghirri P, Putignano E, Sale A, Viegi A, Berardi N, Boldrini A, Cioni G, Maffei L. Massage accelerates brain development and the maturation of visual function. J Neurosci. 2009 May 6;29(18):6042-51. doi: 10.1523/JNEUROSCI.5548-08.2009.
PMID: 19420271BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Monica Fumagalli, MD, PhD
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- PRINCIPAL INVESTIGATOR
Beatrice Bodega, PhD
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2020
First Posted
November 5, 2020
Study Start
December 3, 2020
Primary Completion
March 21, 2025
Study Completion
March 30, 2025
Last Updated
May 1, 2025
Record last verified: 2025-04